Biosimilars AI
The only tool that gives you access to everything you need to know about biologics and biosimilars at your fingertips
What is Biosimilars AI?
The first-ever cloud-based machine learning tool that can be custom trained on your internal data (clinical studies, SOPs, articles, etc.). No more wasted time looking through shared drives and folders. Information is now at your fingertips! Stop wasting countless hours looking for the information you need on biologics and biosimilars. Our AI tool will save incredible time so that you can use resources more efficiently.
Enhance Your Biosimilars knowledge with a Fast & Secure AI Tool
Our AI tool is trained on everything you need to know in biologics and biosimilars, offering unparalleled customization by incorporating your specific data, such as clinical insights, SOPs, guidances, etc.
How it Works?
Artificial Intelligence chat bot that is trained on everything related to biologics and biosimilars
Can be used to answer any and all questions regarding biologics and biosimilars
A powerful, cloud based tool that uses a sophisticated AI enabled machine learning language model to harness important information rapidly, securely and accurately.
Frequently Asked Questions
How to use this AI tool?
This tool serves as an invaluable resource for anyone seeking information about biologics and biosimilars. It offers rapid and accurate answers to your queries, drawing from a vast database of meticulously curated information. Whether you're a researcher, healthcare professional, student, or simply someone interested in understanding these complex topics, this tool can provide you with comprehensive insights, saving you time and effort in your quest for knowledge.
Who is the ACMA?
ACMA, the Accreditation Council for Medical Affairs, sets quality and competency standards for the life sciences and pharma industry. Established in 2015, it's an independent accrediting body in the life sciences sector. ACMA credentials individuals and accredits practices to ensure rigorous quality/competency standards globally, advancing patient care.
What is the difference between external and internal data?
When you choose internal data, the AI exclusively sources answers from the documents you've trained Biosimilars AI with. Conversely, selecting external data allows the AI to utilize ACMA's comprehensive biologics and biosimilars data compendium to respond to your queries.
What type of documents can be trained to Biosimilars AI ?
Biosimilars AI can be trained with a range of file formats, including PDFs, text files, Excel documents, images, and we are actively working on incorporating compatibility for audio files, doc files, and video files into our roadmap.
What types of questions can this tool answer?
This tool is designed to answer a broad spectrum of questions related to biologics and biosimilars. You can ask about definition, inquire about the regulatory processes surrounding biosimilars, explore clinical applications, understand manufacturing techniques, and much more.
Information when you need it. Now.
•
It can provide valuable insights & information allowing the user to ask questions and get answers in seconds. Saving precious company time. This means shared drives and unorganized files are a thing of the past. Time that is wasted looking for the right doc or information diminishes.
•
AI can improve process efficiency and business insights. You can ultimately better support your stakeholders by providing information quickly. That includes your KOLs who want the most up-to-date information.
•
Rapidly access accurate & reliable information. Our AI is trained on the largest compendium of data in the field of biologics and biosimilars. It's continually updated, accurate, and compliant. No more searching aimlessly on the internet or worrying about whether an uncustomized AI tool is reliable enough for your company.
